Acknowledgements
We Gratefully Acknowledge the Following Company for Providing an Educational Grant
AstraZeneca
We Gratefully Acknowledge the Following Companies for Providing Exhibit Support
- AbbVie Hematology
- Abbvie Solid Tumors
- Adaptive Biotechnologies
- ADC Therapeutics
- Agios Pharmaceuticals
- Amgen Thoracic Oncology
- Amgen Hematology Oncology
- Astellas Oncology
- AstraZeneca
- AstraZeneca G2 Oncology
- AstraZeneca Lung Cancer Portfolio
- AstraZeneca Oncology Breast Portfolio
- AstraZeneca Oncology GI
- Autolus
- Azurity Pharmaceuticals
- Bayer Pharmaceuticals
- BeOne Medicines
- Blueprint Medicines
- Boehringer Ingelheim
- Bristol Myers Squibb Hematology
- Bristol Myers Squibb Oncology
- Daiichi Sankyo(2)
- Eisai
- Exelixis
- Gamida Cell
- Genentech
- Genmab
- Geron
- Gilead Oncology
- GSK
- Guardant Health
- Immunocore
- Incyte
- Incyte Hematology GVH/MPN
- Iovance
- Ipsen Biopharmaceuticals
- Jazz Pharmaceuticals
- Johnson & Johnson
- Karyopharm Therapeutics
- Kyowa Kirin
- Lilly
- Merck
- Natera
- Novartis CAR-T
- Novartis Oncology
- Novocure
- Nuvation Bio
- Pfizer Oncology
- Pfizer Oncology Breast
- Pfizer Precision Medicine
- Pharmacyclics, an AbbVie Company
- PharmaEssentia
- Regeneron
- Replimune
- Sanofi
- SecuraBio
- Servier Pharmaceutical
- Sobi
- SpringWorks Therapeutics
- Stemline
- Sumitomo Pharma
- Syndax Pharmaceutical
- Taiho Oncology
- Takeda Oncology Solid Tumor
- Takeda Oncology Hematology